HealthAugust 19, 2025

Hot topics for NACDS TSE: Retail pharmacies building health services and addressing margin

Heading into its major annual industry event, the retail pharmacy industry is looking for ways to increase revenue, streamline operations, and invest in community healthcare.

I look forward every year to the NACDS Total Store Expo, the largest gathering of retailers and pharmacy leaders in North America, to meet with colleagues and hear what the industry is excited and worried about, as well as the latest innovations on the horizon.

In a year that has seen record challenges for pharmacy businesses, but also shown some remarkable possibilities for growth and transformation, I anticipate being part of some enlightening conversations.

Here’s what I expect to be top-of-mind for pharmacy leaders at the Total Store Expo:

Pharmacies as community health hubs

While each organization may approach this idea in a different way, it’s pretty much universally accepted that the next phase in the evolution of retail pharmacy is to embrace the transition into community health hubs, focused as much on nonemergent clinical care services and wellness as they are on the prescription fill business.

Pharmacies have become trusted providers of immunizations over the years, but as they continue to lean into their role as a healthcare center, many may look to explore expanding other services, including:

  • Medication therapy management (MTM) services: When pharmacists are allowed the time to provide detailed medication reviews, pharmacotherapy consults, and anticoagulation management for patients with complex treatments, it has been shown to help reduce adverse drug events.
  • Test and treat initiatives: Depending on legislation and accreditation requirements in their state, pharmacists could be empowered to provide simple treatment regimens for certain diseases – like COVID-19, influenza, or strep – that could be diagnosed from point-of-care tests.
  • Food as medicine: By adding nutritional consulting and dietary interventions, pharmacies offering these programs could support care for patients with diabetes, heart disease, obesity, and more.

Reimbursement for pharmacy-provided services

It's an ongoing issue, but sure to still be of concern this year: How do we support the pharmacist practicing at the top of their license? The industry is always advocating to ensure pharmacists are covered and reimbursed for providing patient-care services beyond medication dispensing that will be needed to build out the community care model.

Current provider status legislation and how we can advocate for it is likely to be a frequent topic of discussion, especially considering that NACDS recently commended the Ensuring Community Access to Pharmacist Services Act, which would allow for federal Medicare coverage of pharmacist-provided services currently only authorized at the state level.

Looking for solutions to margin problems

The biggest pain point right now in retail pharmacy is margin. As leaders are looking to find ways to address margin pressures, there are two primary directions they are likely to be interested in exploring:

Workflow efficiency and automation

One route you can take to address margin is to automate as much of the existing dispensing business as you possibly can. That's why over the last three years, you’ve seen a lot of retailers leaning into central fill as a solution. By getting the prescription-filling for chronic conditions out of the stores as much as we can and putting that in a center where those tasks are fully automated, you’re being more efficient with the workflow and with human resources. In-store pharmacists have more time to focus on direct consumer needs and patient care services.

Margin and efficiency can also be addressed in more incremental ways by adding digital options in any area where workflow is causing unnecessary stress or waste for pharmacists. For example, digital medication education, distributed to patients through a QR code on their prescription label, reduces the operating expenses of printers, paper, and staples to prepare patient leaflets. And believe it or not, even the time saved in going back-and-forth to the printer and refilling paper is cited by pharmacy staff as a meaningful improvement in administrative burden.

Whether it’s automation, adding efficiencies, or giving more responsibility to pharmacy techs within foundational filling and dispensing to allow the pharmacist to elevate their time more toward clinical services, it all works together. But at the core it's all about margin.

Seeking new margin-rich service lines

In order for the retail pharmacy industry to reposition themselves to be community health centers, they know they’re going to have to expand outside of the core dispensing and filling of medications – whether that’s expanding MTM services, building out capabilities for test and treat, or maybe hiring a dietician to pursue food as medicine.

However, the fact is, if pharmacies want to get into these margin-rich businesses, it means they will have to do a little bit of investing upfront. Most understand that the margin will ultimately more than make up for the investment.

When it comes to dispensing, not all prescriptions are created equal from a margin perspective.

Specialty medications will continue to be an important conversation, as they can be challenging and complex to dispense, but also offer an opportunity to boost revenue to pharmacies. While various healthcare entities define specialty meds differently (high cost, complexity of administration, seriousness of the condition they treat), the fact remains, when appropriate to dispense them, these drugs represent a potential for pharmacies to earn a higher positive net income after costs while also meeting important patient needs.

Among non-specialty, margin-rich opportunities, many pharmacies are eying and will be discussing pet medications.

Most consumers don’t have pet insurance, so they are paying for pet meds with cash. And while they used to just get them at the veterinary clinic, savvy consumers are now more likely to shop around for deals, just like they would for their own meds – whether that’s online or through a local pharmacy.

We forced the consumer to become more educated by the fact that prescriptions aren't the same price everywhere you go, and now they’re putting their knowledge to the test. The reason pet med shoppers are so interesting to retail pharmacy is because it's a total cash business, and there’s no PBM negotiating a reimbursement rate and then adding DIR fees on top of that. It benefits the consumer to save on pet meds, and it benefits the pharmacy from a margin standpoint.

Wolters Kluwer innovates for retail pharmacy

While focusing on community health and clinical services may require upfront investment, pharmacies will ultimately benefit by adapting to patient demand, drawing more consumers with new or expanded service lines that drive new streams of revenue.

The right evidence-based technology can play a role in smoothing these transformations and alleviating some administrative management. That’s why Wolters Kluwer is constantly developing solutions specifically for retail pharmacy teams from the UpToDate® Digital Architect platform:

  • Digital Medication Education – With more than 3,900 digitally-accessible medication leaflets, pharmacy teams can reduce paper costs, save time filling prescriptions, and connect patients to the most current medication information across 19 languages. To date, Digital Medication Education is preferred by more than 11,000 pharmacies and used to support over 800 million prescriptions.
  • Consumer Education – Using medication leaflets as a digital front door, patients can access interactive education programs and multimedia content mapped to their specific condition designed to drive patient engagement and adherence.

To learn more about our innovations for retail pharmacy workflow, consumer education, and community care clinical services, and to discuss how we can help your organization meet its goals, set up a meeting with a Wolters Kluwer representative at NACDS TSE 2025.

Schedule A Meeting
Not Coming To NACDS TSE? Contact Us
Garry Marshall
Sr. Director, Pharmacy Strategy, Clinical Effectiveness, Wolters Kluwer Health
Garry Marshall, MBA, is the Senior Director of Pharmacy Strategy at Wolters Kluwer Health, where he leads the pharmacy business strategy for the UpToDate and Medi-Span solutions.
Back To Top